Efthymios Deliargyris

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CTSO

Current role

1 call Latest call 2023-11-09

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Cytosorbents Corp (CTSO)	Chief Medical Officer	$432,586	$78,121	$70,000	$70,248	—	$12,500	$663,455
2024	Cytosorbents Corp (CTSO)	Chief Medical Officer	$363,336	$162,985	$58,255	$216,366	—	$12,500	$813,442
2023	Cytosorbents Corp (CTSO)	Chief Medical Officer	$408,100	$164,778	$194,150	$276,204	—	$12,500	$1,055,732
2021	Cytosorbents Corp (CTSO)	Chief Medical Officer	$408,100	$101,005	$359,600	$313,513	—	$12,500	$1,194,718
2020	Cytosorbents Corp (CTSO)	Chief Medical Officer	$253,212	$101,640	$131,800	$331,912	—	$8,654	$827,218

Earnings-call appearances and filed executive appointments or departures, newest first.